Fundamental dimension Equity attribute | EMRPeer $162.60▲+1.44% Cap $90.70BP/E 35.4x QuantScore49/100 | ABBNYPeer $82.09▼-1.45% Cap $148.5BP/E 29.8x QuantScore38/100 | DOVLeader $199.20▲+1.90% Cap $26.83BP/E 23.1x QuantScore58/100 |
|---|---|---|---|
1. QuantScore pillars0–100 per pillar · click a ticker for the factor breakdown | |||
Technical | |||
73/100 |
31/100 |
73/100 |
Valuation Multiples, PEG & DCF upside | 48/100 | 46/100 | 62/100 |
Health Piotroski, Altman Z, leverage & liquidity | 54/100 | 72/100 | 79/100 |
Growth Revenue / earnings growth & margins | 35/100 | 34/100 | 18/100 |
Sentiment Analyst ratings, targets & revisions | 38/100 | 8/100 | 59/100 |
2. Valuation multiples & capital pricingGreen highlight = best-in-class (lowest positive multiple) |
Trailing P/E | 35.4x | 29.8x | 23.1x |
Forward P/E (next FY) | 24.8x | 24.5x | 18.6x |
EV / EBITDA (TTM) | 19.2x | 19.6x | 14.7x |
Price / Sales | 4.9x | 4.0x | 3.1x |
Price / Free Cash Flow | 26.2x | 30.4x | 22.6x |
PEG ratio | -20.68 | 2.12 | -0.49 |
3. Financial health & solvencyLatest filings |
Piotroski F-Score | 9 / 9 | 6 / 9 | 8 / 9 |
Altman Z-Score | 4.59 (Safe) | 5.06 (Safe) | 5.40 (Safe) |
Total debt / equity | 0.68 | 0.51 | 0.43 |
Quick ratio | 0.7x | 1.1x | 1.4x |
Interest coverage | 6.8x | 23.7x | 12.7x |
4. Growth & margins trajectoryLatest fiscal year |
Revenue growth YoY | +3.0% | +1.1% | +4.5% |
Net income growth YoY | +16.5% | +20.3% | -59.4% |
Gross margin (TTM) | 53.2% | 40.1% | 39.7% |
Operating margin (FY) | 19.6% | 18.2% | 17.0% |
FCF margin (FY) | 14.8% | 13.4% | 13.8% |
5. Trailing price performancePrice change over period |
1M return | +3.5% | -16.1% | +6.0% |
3M return | +9.2% | -15.0% | -1.5% |
6M return | +14.3% | -17.4% | -11.4% |
Year to date | +21.8% | +11.0% | +2.0% |
1Y return | +21.8% | +10.4% | +12.3% |
3Y return | +78.1% | +147.9% | +50.5% |
6. DCF valuation & street consensusDCF model · analyst consensus |
DCF model fair value | $102.46 -37.0% premium | $32.27 -60.7% premium | $140.45 -29.5% premium |
Wall Street consensus target | $167.18 +2.8% · range $135.00–$186.00 | $58.00 -29.3% · range $58.00–$58.00 | $243.10 +22.0% · range $219.00–$265.00 |
Consensus stance | 53% Buy40% Hold7% Sell | 40% Buy52% Hold8% Sell | 68% Buy32% Hold-0% Sell |